FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 18:46:09 23/05/2024 BST | ||
| 9.38 EUR | -6.48% |
|
| Current month | +7.97% | ||
| 1 month | +30.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 9.38 | -6.48% |
| 22/05/24 | 10.03 | -1.28% |
| 21/05/24 | 10.16 | -3.24% |
| 20/05/24 | 10.5 | +1.25% |
| 17/05/24 | 10.37 | -0.29% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 06:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BU |
| ISIN | DE000HD36BU4 |
| Date issued | 28/02/2024 |
| Strike | 112.6 $ |
| Maturity | Unlimited |
| Parity | 10.79 : 1 |
| Emission price | 10.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.92 € |
|---|---|
| Lowest since issue | 7.36 € |
| Spread | 0.02 € |
| Spread % | 0.21% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
225.2
USD
Average target price
287.3
USD
Spread / Average Target
+27.57%
- Stock Market
- Certificates
- Certificat
